Management Team
| | |  | Frederic Hammel CEO Frederic Hammel is a former student from the Ecole Normale Superieure, Paris. He has a Master of Biochemistry, Pharmacology and an MBA. He was previously General Manager of a medtech success story growing in 5 years from 15 people/2.5M€ to more than 80 people/10M€. He has 15 years experience in the pharmaceutical / medical device industry. |  | Arnaud Foussat CSO Graduate of Institut Pasteur of Paris, Dr. Foussat obtained his Ph.D. degree from the University of Paris VII. In September 2000, Dr. Foussat joined a French academic laboratory located in Nice (INSERM U576) and dedicated to the study of regulatory Tr1 lymphocytes. Dr. Foussat focused his scientific efforts on the elucidation of the migratory pathways of Tr1 cells in normal and pathological conditions. In September 2004, Dr. Foussat was hired by TxCell as a team leader to develop proofs of concept for Tr1 cell treatments of chronic inflammatory diseases. He acquired responsibility of CSO in late 2005. | |
Miguel Forte CMO
Miguel Forte holds a MD and a PhD, an accreditation as Specialist in Infectious Diseases, a certificate on Health Economics of Pharmaceuticals and Medical Technologies (HEP). He is Fellow of the Faculty of Pharmaceutical Medicine of the RCP (UK). After several Clinical, Academic and Regulatory positions in the Public Sector in Portugal, he spent six years with Bristol-Myers Squibb successively as Medical Director (1998-2000), Executive Director Infectious Diseases, Immunology and Dermatology (2000-2002) and Vice-President International Medical Organization (2002-2003) in Portugal and Belgium. In 2004, Miguel Forte joined Nabi Pharmaceuticals as Vice-President Clinical, Medical and Regulatory Affairs Europe for two years. In February 2006 he became Vice-President Global Medical Affairs Inflammation Worldwide at UCB, before joining TxCell as Chief Medical Officer in January 2010.
| | | Virginie Neveu Manufacturing Director Virginie Neveu obtained her Master Degree in Biochemistry from CNAM (Conservatoire National des Arts et Métiers). Before joining TxCell in July 2007, she worked for several major biopharceutical companies, including Sanofi Pasteur and Bio-Rad. She also held a variety of positions in the bio-industrialized field such as manufacturing manager and support process manager for Sanofi Pasteur Flu Platform. |  | Christophe Sarlot CFO Christophe Sarlot joined TxCell as Finance Director in January 2008. He acquired 4 years experience as senior auditor in finance audit (KPMG) and he held a position as a finance analyst in Amadeus Sophia Antipolis for 3 years. Christophe Sarlot graduated from business school (CERAM Sophia Antipolis) with a specialization in Audit and Finance. |
|
